Department of Pediatrics, Fribourg Hospital HFR, Fribourg, Switzerland; ARCIM Institute, Filderklinik, Filderstadt, Germany.
ARCIM Institute, Filderklinik, Filderstadt, Germany; Department of Pediatrics, University Hospital Tübingen, Germany.
Complement Ther Med. 2018 Oct;40:179-184. doi: 10.1016/j.ctim.2017.10.005. Epub 2017 Oct 24.
For the pilot phase of an integrative pediatric program, we defined inpatient treatment algorithms for bronchiolitis, asthma and pneumonia, using medications and nursing techniques from anthroposophic medicine (AM). Parents could choose AM treatment as add-on to conventional care.
To evaluate the 18-month pilot phase, parents of AM users were asked to complete the Client Satisfaction Questionnaire (CSQ-8) and a questionnaire on the AM treatment. Staff feedback was obtained through an open-ended questionnaire. Economic data for project set-up, medications and insurance reimbursements were collected.
A total of 351 children with bronchiolitis, asthma and pneumonia were hospitalized. Of these, 137 children (39%) received AM treatment, with use increasing over time. 52 parents completed the questionnaire. Mean CSQ-8 score was 29.77 (95% CI 29.04-30.5) which is high in literature comparison. 96% of parents were mostly or very satisfied with AM; 96% considered AM as somewhat or very helpful for their child; 94% considered they learnt skills to better care for their child. The staff questionnaire revealed positive points about enlarged care offer, closer contact with the child, more relaxed children and greater role for parents; weak points included insufficient knowledge of AM and additional nursing time needed. Cost for staff training and medications were nearly compensated by AM related insurance reimbursements.
Introduction of anthroposophic treatments were well-accepted and led to high parent satisfaction. Additional insurance reimbursements outweighed costs. The program has now been expanded into a center for integrative pediatrics.
在综合儿科项目的试点阶段，我们使用顺势疗法的药物和护理技术为毛细支气管炎、哮喘和肺炎制定了住院治疗算法。父母可以选择顺势疗法治疗作为常规护理的附加治疗。
为了评估 18 个月的试点阶段，我们要求选择顺势疗法治疗的父母完成客户满意度问卷（CSQ-8）和关于顺势疗法治疗的问卷。通过开放式问卷获得员工反馈。收集了项目设置、药物和保险报销的经济数据。
共有 351 名毛细支气管炎、哮喘和肺炎患儿住院。其中，137 名儿童（39%）接受了顺势疗法治疗，随着时间的推移，使用量有所增加。52 名家长完成了问卷。平均 CSQ-8 得分为 29.77（95%CI 29.04-30.5），在文献比较中得分较高。96%的家长对顺势疗法非常满意或满意；96%的家长认为顺势疗法对孩子有所帮助；94%的家长认为他们学会了更好地照顾孩子的技能。员工问卷显示，扩大护理范围、与孩子更密切接触、孩子更放松、家长的角色更重要等方面是积极的；不足之处包括对顺势疗法的知识不足和需要额外的护理时间。员工培训和药物的成本几乎被相关的保险报销所抵消。
顺势疗法的引入得到了很好的接受，并导致了家长的高度满意。额外的保险报销弥补了成本。该项目现已扩展为综合儿科中心。
